Who Owns United Therapeutics Stock?
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 102.14%
- Institutions (% of float)
- 104.73%
- Held by insiders
- 2.47%
- Institutional holders
- 1,205
- Institutions 97.5%
- Insiders 2.5%
- Public and other 0.0%
Who owns United Therapeutics stock?
Institutional investors own about 102.1% of United Therapeutics's shares, spread across 1,205 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.47% of UTHR.
The largest institutional holders are Blackrock Inc. (13.09%), Avoro Capital Advisors LLC (6.52%) and State Street Corporation (4.58%). Together, the top 10 institutions control 47.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their UTHR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of UTHR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.58M | 13.09% | +5.3% |
| Avoro Capital Advisors LLC | 2.78M | 6.52% | +5.6% |
| State Street Corporation | 1.95M | 4.58% | +2.9% |
| Vanguard Capital Management LLC | 1.93M | 4.53% | +0.6% |
| Vanguard Portfolio Management LLC | 1.91M | 4.49% | -0.4% |
| Renaissance Technologies, LLC | 1.68M | 3.94% | -1.9% |
| Wellington Management Group, LLP | 1.38M | 3.24% | -39.1% |
| Amundi | 988.82K | 2.32% | +351.3% |
| Geode Capital Management, LLC | 974.99K | 2.29% | -2.2% |
| Jupiter Topco LLC | 831.13K | 1.95% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of UTHR
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 1.53M | 3.59% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.35M | 3.16% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 973.49K | 2.29% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 719.38K | 1.69% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 486.56K | 1.14% |
| iShares Trust-iShares Biotechnology ETF | 323.43K | 0.76% |
| SPDR S&P MIDCAP 400 ETF TRT-State Street SPDR S&P Mid Cap 400 ETF TRT | 317.13K | 0.74% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 308.33K | 0.72% |
| Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Quality ETF | 296.32K | 0.70% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 291.57K | 0.68% |
Frequently asked questions
Who is the largest shareholder of United Therapeutics?
Blackrock Inc. is the largest institutional shareholder of UTHR, owning 13.09% of shares outstanding (5.58M shares) as of its latest 13F filing.
What percentage of United Therapeutics is owned by institutions?
Institutions own about 102.1% of UTHR shares and 104.7% of the public float.
How much of United Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.47% of UTHR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.